Max Robotics — Global Service Robot Directory + US Certification

About

T. Sarrazin is a radiation oncology researcher whose work has centered on advancing stereotactic radiotherapy technologies, with a particular focus on robotic and image-guided treatment systems. Best known for pioneering contributions to CyberKnife® implementation in France, Sarrazin was among the earliest investigators to systematically evaluate this robotic radiosurgery platform for both intracranial and extracranial applications. Their 2007 technical overview of CyberKnife® stereotactic radiotherapy, garnering 46 citations, became a foundational reference for clinicians navigating this emerging technology, while a 2009 study on extracranial stereotactic radiotherapy (35 citations) provided critical early clinical data supporting its broader adoption. Sarrazin was also part of a nationally significant initiative when the French Institut National du Cancer selected three sites — including Lille, Nancy, and Nice — to implement and evaluate robotic radiotherapy, placing their research at the forefront of French oncological innovation. More recently, a 2016 contribution to Monte Carlo-based treatment plan quality assurance (16 citations) demonstrated a sustained commitment to improving treatment precision and safety across advanced platforms including Tomotherapy. Collectively, Sarrazin's work has meaningfully shaped clinical standards and technical benchmarks in modern precision radiotherapy.